General
Preferred name
curcumin
Synonyms
NSC32982 ()
Diferuloylmethane ()
Natural Yellow 3 ()
Indian Saffron ()
Turmeric yellow ()
CI 75300 ()
C.i. 75300 ()
NSC-687842 ()
Merita earth ()
E 100 ()
E-100 ()
C.i. natural yellow 3 ()
Haldar ()
NSC-32982 ()
Jianghuangsu ()
Curcumin e100 ()
INS-100(I) ()
Kurkum ()
CI-75300 ()
Lipocurc ()
Kacha haldi ()
Nanocurc ()
E100 ()
INS NO. 100(I) ()
P&D ID
PD011359
CAS
15845-47-3
8024-37-1
458-37-7
Tags
available
covalent binder
drug
natural product
Drug indication
Chronic lymphocytic leukemia
Solid tumour/cancer
Drug Status
approved
investigational
Max Phase
3.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION Curcumin (Diferuloylmethane), a natural phenolic compound, is a p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. Curcumin shows inhibitory effects on NF-¦ÊB and MAPKs, and has diverse pharmacologic effects including anti-inflammatory, antioxidant, antiproliferative and antiangiogenic activities. Curcumin induces stabilization of Nrf2 protein through Keap1 cysteine modification.
DESCRIPTION Curcumin (Natural Yellow 3) is a phenolic natural product, an inhibitor of histone acetyltransferase p300/CREB (IC50=25 ??M) with specificity. Curcumin has a wide range of pharmacological activities such as antitumor, anti-inflammatory and antioxidant.
DESCRIPTION Curcumin's physicochemical properties imply that it is an implausible clinical lead . It is unstable, reactive, and nonbioavailable, and has been identified as having attributes of both PAINS (pan-assay interference compounds) and IMPS (invalid metabolic panaceas) compounds. (GtoPdb)
DESCRIPTION Curcumin (Natural Yellow 3) is a phenolic natural product, an inhibitor of histone acetyltransferase p300/CREB (IC50=25 μM) with specificity. Curcumin has a wide range of pharmacological activities such as antitumor, anti-inflammatory and antioxidant. (TargetMol Bioactive Compound Library)
Cell lines
111
Organisms
23
Compound Sets
18
Bioprocess diversity set
Cayman Chemical Bioactives
ChEMBL Drugs
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
CovalentInDB
CZ-OPENSCREEN Bioactive Library
DrugBank
DrugBank Approved Drugs
DrugMAP
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NIH Mechanistic Set
Nuisance compounds in cellular assays
Probe Miner (suitable probes)
ReFrame library
TargetMol Bioactive Compound Library
External IDs
338
Properties
(calculated by RDKit )
Molecular Weight
368.13
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
8
Ring Count
2
Aromatic Ring Count
2
cLogP
3.37
TPSA
93.06
Fraction CSP3
0.14
Chiral centers
0.0
Largest ring
6.0
QED
0.55
Structural alerts
3
aggregator (Aggregator Advisor)
Aggregators
aggregator (ZINC)
Aggregators
Nonspecific/NOS
Curcuminoids
Nuisance compounds
Custom attributes
(extracted from source data)
Target
Mitophagy
Epigenetic Reader Domain
Ferroptosis
Histone Acetyltransferase
Influenza Virus
Keap1-Nrf2
p300 histone acetylatransferase
Biological process
Glycosylation & protein folding/targeting, cell wall biogenesis
Pathway
NF-¦ÊB
NF-??
Apoptosis
Autophagy
Chromatin/Epigenetic
DNA Damage/DNA Repair
Immunology/Inflammation
Microbiology/virology
Anti-infection
Epigenetics
NF-κB
Source data